Researchers performed portal vein pressure measurements on hepatitis C patients who recovered with interferon-free treatment.
Here are three things to know:
1. The study shows if patients undergo hepatitis C treatment at an early stage, portal vein hypertension also diminishes.
2. The study’s findings indicate hepatitis C patients may not have to take medication to prevent portal vein hypertension, which is responsible for liver cirrhosis complications.
3. Additionally, patients may not have to undergo endoscopic check-ups as often as they had to in the past.
More articles on GI/endoscopy:
Cantel Medical’s short interest drops 7.05%: 3 points
Use of Allurion Technologies’ Elipse gastric balloon results in successful weight loss: 4 things to know
Healthmark adds Endo Bin & Trolley Set; enables controlled delivery & retrievable system for endoscopes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.